Dextromethorphan: Difference between revisions
ClaireLewis (talk | contribs) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
* | *30mg PO q6-8h | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
*cough/cold products should NOT be used in children younger than 4 years | *cough/cold products should NOT be used in children younger than 4 years | ||
| Line 40: | Line 40: | ||
==See Also== | ==See Also== | ||
[[Dextromethorphan toxicity]] | |||
==References== | ==References== | ||
Micromedex | Micromedex | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 07:30, 4 March 2017
Administration
- Type: Anti-tussive
- Dosage Forms:
- Routes of Administration:
- Common Trade Names: Active ingredient in many combination OTC cough/cold medications
Adult Dosing
- 30mg PO q6-8h
Pediatric Dosing
- cough/cold products should NOT be used in children younger than 4 years
Special Populations
- Pregnancy Rating: A
- Lactation risk: infant risk minimal
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
- MAOI use concurrently or within past 14d
Adverse Reactions
Serious
- Serotonin syndrome (if used with other serotonergic agents)
- Recreational abuse
Common
- Dizziness
- Fatigue/somnolence
Pharmacology
- Half-life:
- Metabolism: Liver
- Excretion: Renal
Mechanism of Action
Comments
See Also
References
Micromedex